Ingredient

Basic Violet 2

Basic Violet 2 is flagged for pregnancy, breastfeeding, trying to conceive, postpartum, PCOS and general use. The concern behind the strongest flag is carcinogen concern and absorbed into the body.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Not Recommended
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
6 of 6
Counting avoid, high risk and medium risk
Irritancy
3 of 5
Higher means more likely to sting or redden
PregnancyAVOID

Basic Violet 2 and pregnancy

Not Recommended

Basic Violet 2 (crystal violet/gentian violet) is a synthetic triarylmethane dye used as a colorant in cosmetics. While it has historical medicinal uses, modern safety assessments have identified serious health concerns that make it inappropriate for use during pregnancy. The IARC classifies crystal violet as a possible human carcinogen based on animal studies showing tumor formation. The compound can be absorbed through the skin and has been shown to cross biological barriers. Studies indicate mutagenic potential and cellular toxicity. Given these concerns and the potential for fetal exposure through maternal systemic absorption, ACOG's principles of avoiding known carcinogens during pregnancy apply. The EU Cosmetics Regulation restricts this ingredient specifically due to safety concerns. Regulatory bodies including the EU have severely restricted or banned Basic Violet 2 in cosmetics due to carcinogenicity concerns. Pregnant women should completely avoid products containing this ingredient. The FDA has not approved it for cosmetics in the eye area, and many experts recommend avoiding it entirely during pregnancy regardless of application site.

BreastfeedingAVOID

Basic Violet 2 and breastfeeding

Not Recommended

Basic Violet 2 is classified as a possible carcinogen and mutagen by international agencies. The compound can be absorbed through the skin and potentially transferred to breast milk due to its chemical properties and ability to cross biological membranes. Given the carcinogenicity and mutagenicity concerns identified by the IARC and ECHA, and the potential for infant exposure through breast milk or direct contact, the AAD and lactation specialists recommend complete avoidance during breastfeeding. The risk of infant exposure to a potential carcinogen outweighs any cosmetic benefits. The EU has restricted this ingredient in cosmetics due to safety concerns, and it is banned in products that contact mucous membranes. Breastfeeding women should avoid all products containing Basic Violet 2 to prevent any risk of infant exposure.

PostpartumAVOID

Basic Violet 2 and postpartum

Not Recommended

For postpartum women not breastfeeding, the primary concerns with Basic Violet 2 are its classification as a possible carcinogen and mutagen by international regulatory bodies. The ECHA and IARC have documented evidence of tumor formation in animal studies and mutagenic potential. While the immediate concern of infant exposure through breast milk is removed, the long-term health risks associated with using a potential carcinogen remain. The EU has restricted this ingredient in cosmetics, and many countries have banned its use in products applied to skin. Most dermatologists recommend avoiding ingredients with carcinogenic potential regardless of life stage.

Trying to ConceiveAVOID

Basic Violet 2 and trying to conceive

Not Recommended

Women trying to conceive should avoid Basic Violet 2 due to its classification as a possible carcinogen and mutagen. The mutagenic potential raises concerns about DNA damage that could theoretically affect reproductive cells or early embryonic development. While specific fertility studies on Basic Violet 2 are limited, the general principle of avoiding known mutagens and potential carcinogens during the preconception period is recommended by reproductive health specialists. The EU restrictions on this ingredient support a conservative approach during the TTC period.

PCOSAVOID

Basic Violet 2 and PCOS

Not Recommended

Basic Violet 2 has no specific interactions with PCOS or hormonal conditions, but its classification as a possible carcinogen by the IARC makes it a high-risk ingredient for all users regardless of hormonal status. The concerns about mutagenicity and carcinogenicity apply equally to women with PCOS. There is no hormonal interference, but the general health risks associated with using a restricted colorant that has been linked to cancer formation are significant. Women with PCOS should avoid this ingredient not due to hormonal concerns but because of its established health risks that affect all populations. The EU restrictions on this ingredient reflect serious safety concerns that warrant avoidance.

General UseAVOID

Basic Violet 2 and general use

Not Recommended

Basic Violet 2, also known as crystal violet or gentian violet, is a synthetic dye with a concerning safety profile. The International Agency for Research on Cancer (IARC) classifies it as a possible human carcinogen (Group 2B) based on sufficient evidence of carcinogenicity in animal studies. Research has shown it can cause tumor formation and has mutagenic properties. The ECHA has documented that crystal violet can be absorbed through the skin and has identified it as a substance of concern. Studies show it can cause skin irritation and allergic reactions in some individuals. The carcinogenicity concerns are particularly relevant with repeated or chronic exposure, which is typical in cosmetic use. The EU Cosmetics Regulation specifically restricts Basic Violet 2, prohibiting its use in products that come into contact with mucous membranes and limiting it to rinse-off products only at very low concentrations. Many countries have banned it from cosmetics entirely. The FDA has not approved it for use in eye area cosmetics. Most safety experts recommend avoiding this ingredient and choosing safer colorant alternatives that are widely available.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients suggested in place of Basic Violet 2, each one with its own page here.

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store